N-Boc-反式-4-氟-L-脯氨酸甲酯
|
B119049-250mg
|
≥97% |
203866-18-6 |
250mg
|
¥ 29.9
|
现货 |
阿拉丁 |
1-BOC-哌啶-4-甲醛
|
B119047-5g
|
≥97% |
137076-22-3 |
5g
|
¥ 30.9
|
现货 |
阿拉丁 |
1-BOC-哌啶-4-甲醛
|
B119047-1g
|
≥97% |
137076-22-3 |
1g
|
¥ 25.9
|
现货 |
阿拉丁 |
1-Boc-2-(氨甲基)吡咯烷
|
B119044-5g
|
≥88% |
177911-87-4 |
5g
|
¥ 587.9
|
现货 |
阿拉丁 |
1-Boc-2-(氨甲基)吡咯烷
|
B119044-1g
|
≥88% |
177911-87-4 |
1g
|
¥ 152.9
|
现货 |
阿拉丁 |
1-Boc-2-(氨甲基)吡咯烷
|
B119044-250mg
|
≥88% |
177911-87-4 |
250mg
|
¥ 59.9
|
现货 |
阿拉丁 |
1-Boc-3-氧哌嗪
|
B119043-5g
|
≥98% |
76003-29-7 |
5g
|
¥ 54.9
|
现货 |
阿拉丁 |
1-Boc-3-氧哌嗪
|
B119043-1g
|
≥98% |
76003-29-7 |
1g
|
¥ 25.9
|
现货 |
阿拉丁 |
1-Boc-六氢-1,4-二氮杂环庚烷
|
B119041-5g
|
≥96% |
112275-50-0 |
5g
|
¥ 125.9
|
现货 |
阿拉丁 |
1-Boc-六氢-1,4-二氮杂环庚烷
|
B119041-1g
|
≥96% |
112275-50-0 |
1g
|
¥ 29.9
|
现货 |
阿拉丁 |
1-Boc-4-(甲基氨基)哌啶
|
B119037-5g
|
≥97% |
147539-41-1 |
5g
|
¥ 39.9
|
现货 |
阿拉丁 |
1-Boc-4-(甲基氨基)哌啶
|
B119037-1g
|
≥97% |
147539-41-1 |
1g
|
¥ 29.9
|
现货 |
阿拉丁 |
碘化铋
|
B119017-50g
|
PrimorTrace™, ≥99.99% metals basis |
7787-64-6 |
50g
|
¥ 1586.9
|
现货 |
阿拉丁 |
碘化铋
|
B119017-10g
|
PrimorTrace™, ≥99.99% metals basis |
7787-64-6 |
10g
|
¥ 411.9
|
现货 |
阿拉丁 |
纳米钛酸钡
|
B118840-500g
|
≥99.9% metals basis, <100 nm |
12047-27-7 |
500g
|
¥ 390.9
|
现货 |
阿拉丁 |
纳米钛酸钡
|
B118840-100g
|
≥99.9% metals basis, <100 nm |
12047-27-7 |
100g
|
¥ 114.9
|
现货 |
阿拉丁 |
纳米钛酸钡
|
B118840-25g
|
≥99.9% metals basis, <100 nm |
12047-27-7 |
25g
|
¥ 55.9
|
现货 |
阿拉丁 |
舒缓激肽片段2-9
|
B118780-25mg
|
≥97%(HPLC) |
16875-11-9 |
25mg
|
¥ 2869.9
|
现货 |
阿拉丁 |
舒缓激肽片段2-9
|
B118780-5mg
|
≥97%(HPLC) |
16875-11-9 |
5mg
|
¥ 700.9
|
现货 |
阿拉丁 |
舒缓激肽片段2-9
|
B118780-1mg
|
≥97%(HPLC) |
16875-11-9 |
1mg
|
¥ 276.9
|
现货 |
阿拉丁 |
舒缓激肽片段1-7
|
B118779-25mg
|
≥97%(HPLC) |
23815-87-4 |
25mg
|
¥ 1231.9
|
现货 |
阿拉丁 |
舒缓激肽片段1-7
|
B118779-5mg
|
≥97%(HPLC) |
23815-87-4 |
5mg
|
¥ 351.9
|
现货 |
阿拉丁 |
缓激肽片段 1-5
|
B118778-1mg
|
≥97%(HPLC) |
23815-89-6 |
1mg
|
¥ 168.9
|
现货 |
阿拉丁 |
血管舒缓激肽片段1-8,醋酸盐水合物
|
B118776-25mg
|
Moligand™, ≥95%(HPLC) |
15958-92-6 |
25mg
|
¥ 853.9
|
现货 |
阿拉丁 |